(Q35690882)

9 August 2017

1 reference

title

Valproate hepatotoxicity syndrome: hypotheses of pathogenesis (English)

1 reference

9 August 2017

1 reference

1 reference

J. R. Stephens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1502010

2 October 2022

R. H. Levy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1502010

2 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1502010

2 October 2022

publication date

1 June 1992

1 reference

9 August 2017

19 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1502010

Pharmaceutisch weekblad. Scientific edition

2 October 2022

published in

1 reference

9 August 2017

volume

14

1 reference

9 August 2017

issue

3A

1 reference

9 August 2017

page(s)

118-121

1 reference

Effect of valproic acid on hepatic function

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Valproate-associated hepatotoxicity and its biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Valproate-induced hepatic steatogenesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Carnitine deficiency, organic acidemias, and Reye's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Acute changes of blood ammonia may predict short-term adverse effects of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

The renal origin of sodium valproate-induced hyperammonemia in fasting humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Metabolism of valproate to hepatotoxic intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962700

Valproic acid-induced hyperammonemia in mentally retarded adults

21 January 2018

1 reference

12 December 2020

Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy

1 reference

12 December 2020

On the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion

1 reference

12 December 2020

Valproic acid and secondary hyperammonemia

1 reference

12 December 2020

Reye-like syndrome associated with valproic acid therapy

1 reference

12 December 2020

Nutritional influence on serum ammonia in young patients receiving sodium valproate

1 reference

12 December 2020

Serum carnitine during valproic acid therapy

1 reference

12 December 2020

Influence of valproic acid on hepatic carbohydrate and lipid metabolism

1 reference

12 December 2020

Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes

1 reference

12 December 2020

Acute Hepatic Failure Associated with the Use of Sodium Valproate

1 reference

12 December 2020

Evidence of inherited urea cycle defect in a case of fatal valproate toxicity

1 reference

12 December 2020

Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs

1 reference

12 December 2020

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

1 reference

12 December 2020

Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid

1 reference

12 December 2020

Valproate hepatotoxicity: a review and report of two instances in adults

1 reference

12 December 2020

Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid

1 reference

12 December 2020

Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate

1 reference

12 December 2020

Carnitine deficiency: a possible mechanism for valproate hepatotoxicity

1 reference

12 December 2020

Valproic acid associated abnormalities of carnitine metabolism

1 reference

12 December 2020

Fatal liver failure in children on valproate

1 reference

12 December 2020

Sodium valproate-induced hyperammonemia in the rat: role of the kidney.

1 reference

12 December 2020

Hyperammonemia with valproic acid therapy

1 reference

12 December 2020

Valproate causes metabolic disturbance in normal man.

1 reference

12 December 2020

L-carnitine replacement therapy in chronic valproate treatment

1 reference

12 December 2020

The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects.

1 reference

12 December 2020

Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation

1 reference

12 December 2020

Decreased serum carnitine in valproate induced Reye syndrome

1 reference

12 December 2020

Valproate-induced hepatic injury: analyses of 23 fatal cases

1 reference

12 December 2020

The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies

1 reference

12 December 2020

Sodium valproate in the induction of unusual hepatotoxicity

1 reference

12 December 2020

1 reference

12 December 2020

Effect of chronic valproic acid treatment on plasma and urine carnitine levels in children: decreased urinary excretion

1 reference

12 December 2020

Sodium valproate and ornithine carbamyl transferase deficiency

1 reference

12 December 2020

Hepatic hydrolysis of octanoyl-CoA and valproyl-CoA in control and valproate-fed animals

1 reference

12 December 2020

A Direct Hepatotoxic Effect of Valproic Acid

1 reference

12 December 2020

Effect of associated antiepileptic treatment on valproate-induced hyperammonemia

1 reference

12 December 2020

Carnitine deficiency and hyperammonemia associated with valproic acid therapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01962700

1 reference

9 August 2017

1 reference